PT - JOURNAL ARTICLE AU - Natalia Palmou-Fontana AU - David Martínez-Lopez AU - Alfonso Corrales AU - Javier Rueda-Gotor AU - Fernanda Genre AU - Susana Armesto AU - Marcos A. González-López AU - Juan C. Quevedo-Abeledo AU - Virginia Portilla-González AU - Ricardo Blanco AU - José L. Hernandez AU - Javier Llorca AU - Miguel Á. González-Gay AU - Iván Ferraz-Amaro TI - Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis AID - 10.3899/jrheum.190729 DP - 2020 Sep 01 TA - The Journal of Rheumatology PG - 1344--1353 VI - 47 IP - 9 4099 - http://www.jrheum.org/content/47/9/1344.short 4100 - http://www.jrheum.org/content/47/9/1344.full SO - J Rheumatol2020 Sep 01; 47 AB - Objective. Because the addition of carotid ultrasound (US) into composite cardiovascular (CV) risk scores has been found effective for identifying patients with inflammatory arthritis and high CV risk, we aimed to determine whether its use would facilitate the reclassification of patients with psoriatic arthritis (PsA) into the very high Systematic Coronary Risk Evaluation (SCORE) risk category and whether this might be related to disease features.Methods. This was a cross-sectional study involving 206 patients who fulfilled ClASsification for Psoriatic ARthritis criteria for PsA, and 179 controls. We assessed lipid profile, SCORE, disease activity measurements, and the presence of carotid plaques and carotid intima-media thickness by ultrasonography. A multivariable regression analysis, adjusted for classic CV risk factors, was performed to evaluate whether the risk of reclassification could be explained by disease-related features and to assess the most parsimonious combination of risk reclassification predictors.Results. Forty-seven percent of patients were reclassified into a very high SCORE risk category after carotid US compared to 26% of controls (p < 0.001). Patients included in the low SCORE risk category were those who were more commonly reclassified (30% vs 14%, p = 0.002). The Disease Activity Index for PsA (DAPSA) score was associated with reclassification (β 1.10, 95% CI 1.02–1.19; p = 0.019) after adjusting for age and traditional CV risk factors. A model containing SCORE plus age, statin use, and DAPSA score yielded the highest discriminatory accuracy compared to the SCORE-alone model (area under the receiver-operating characteristic curve 0.863, 95% CI 0.789–0.936 vs 0.716, 95% CI 0.668–0.764; p < 0.001).Conclusion. Patients with PsA are more frequently reclassified into the very high SCORE risk category following carotid US assessment than controls. This was independently explained by the disease activity.